Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Jingtao Li, Zhen Cai, Wei Wei, Xia Wang & Xiulan Peng. (2022) Establishment of Prognostic Nomograms for Early-Onset Prostate Cancer Patients: A SEER Database Analysis. Journal of Investigative Surgery 35:7, pages 1581-1590.
Read now
Read now
Jelmer Brüggemann. (2021) Redefining masculinity – Men’s repair work in the aftermath of prostate cancer treatment. Health Sociology Review 30:2, pages 143-156.
Read now
Read now
Kaire Innos, Aleksei Baburin, Andres Kotsar, Ivar-Endrik Eiche & Katrin Lang. (2017) Prostate cancer incidence, mortality and survival trends in Estonia, 1995–2014. Scandinavian Journal of Urology 51:6, pages 442-449.
Read now
Read now
Frederik B. Thomsen, Marta K. Mikkelsen, Rikke B. Hansen, Andrea H. Krug, Anders Glenthøj, Pär Stattin & Klaus Brasso. (2016) Clinical characteristics and primary management of patients diagnosed with prostate cancer between 2007 and 2013: status from a Danish primary referral center. Acta Oncologica 55:12, pages 1456-1460.
Read now
Read now
Anders Bjartell, Matteo Bottai, Josefin Persson, Ola Bratt, Jan-Erik Damber, Pär Stattin & Olof Akre. (2016) Prediction of clinical progression after radical prostatectomy in a nationwide population-based cohort. Scandinavian Journal of Urology 50:4, pages 255-259.
Read now
Read now
Ola Bratt, Stefan Carlsson, Erik Holmberg, Lars Holmberg, Eva Johansson, Andreas Josefsson, Annika Nilsson, Maria Nyberg, David Robinsson, Jonas Sandberg, Dag Sandblom & Pär Stattin. (2013) The Study of Active Monitoring in Sweden (SAMS): A randomized study comparing two different follow-up schedules for active surveillance of low-risk prostate cancer. Scandinavian Journal of Urology 47:5, pages 347-355.
Read now
Read now
Ola Bratt & Martin C. Schumacher. (2011) Natural history of prostate cancer, chemoprevention and active surveillance. Acta Oncologica 50:sup1, pages 116-119.
Read now
Read now
Articles from other publishers (13)
Nicholas Baniak, Lynette M Sholl, Douglas A Mata, Anthony V D’Amico, Michelle S Hirsch & Andres M Acosta. (2021) Clinicopathological and molecular characteristics of prostate cancer diagnosed in young men aged up to 45 years. Histopathology 78:6, pages 857-870.
Crossref
Crossref
Ola Bratt, Linda Drevin, Karl-Göran Prütz, Stefan Carlsson, Lars Wennberg & Pär Stattin. (2020) Prostate cancer in kidney transplant recipients - a nationwide register study. BJU International 125:5, pages 679-685.
Crossref
Crossref
Kerri Beckmann, Beth Russell, Debra Josephs, Hans Garmo, Christel Haggstrom, Lars Holmberg, Pär Stattin, Mieke Van Hemelrijck & Jan Adolfsson. (2019) Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study. BMC Cancer 19:1.
Crossref
Crossref
Mun Su Chung, Myungsun Shim, Jin Seon Cho, Woojin Bang, Sun Il Kim, Sung Yong Cho, Koon Ho Rha, Sung Joon Hong, Kyo Chul Koo, Kwang Suk Lee, Byung Ha Chung & Seung Hwan Lee. (2019) Pathological Characteristics of Prostate Cancer in Men Aged < 50 Years Treated with Radical Prostatectomy: a Multi-Centre Study in Korea. Journal of Korean Medical Science 34:10.
Crossref
Crossref
Subas Neupane, Freddie Bray & Anssi Auvinen. (2016) National economic and development indicators and international variation in prostate cancer incidence and mortality: an ecological analysis. World Journal of Urology 35:6, pages 851-858.
Crossref
Crossref
Andreas Thorstenson, Hans Garmo, Jan Adolfsson & Ola Bratt. (2017) Cancer Specific Mortality in Men Diagnosed with Prostate Cancer before Age 50 Years: A Nationwide Population Based Study. Journal of Urology 197:1, pages 61-66.
Crossref
Crossref
Frederik B. Thomsen, Yasin Folkvaljon, Hans Garmo, David Robinson, Stacy Loeb, Christian Ingvar, Mats Lambe & Pär Stattin. (2016) Risk of malignant melanoma in men with prostate cancer: Nationwide, population-based cohort study. International Journal of Cancer 138:9, pages 2154-2160.
Crossref
Crossref
Anthony D. Ta, Nathan P. Papa, Nathan Lawrentschuk, Jeremy L. Millar, Rodney Syme, Graham G. Giles & Damien M. Bolton. (2015) Increased prostate cancer specific mortality following radical prostatectomy in men presenting with voiding symptoms—A whole of population study. Prostate International 3:3, pages 75-79.
Crossref
Crossref
J. Lyth, H. Eriksson, J. Hansson, C. Ingvar, M. Jansson, J. Lapins, E. Månsson-Brahme, P. Naredi, U. Stierner, G. Ullenhag, J. Carstensen & C. Lindholm. (2015) Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men. British Journal of Dermatology 172:3, pages 700-706.
Crossref
Crossref
Sigrid Carlsson, Fredrik Sandin, Katja Fall, Mats Lambe, Jan Adolfsson, Pär Stattin & Anna Bill-Axelson. (2013) Risk of suicide in men with low-risk prostate cancer. European Journal of Cancer 49:7, pages 1588-1599.
Crossref
Crossref
Christel Häggström, Tanja Stocks, David Ulmert, Tone Bjørge, Hanno Ulmer, Göran Hallmans, Jonas Manjer, Anders Engeland, Gabriele Nagel, Martin Almqvist, Randi Selmer, Hans Concin, Steinar Tretli, Håkan Jonsson & Pär Stattin. (2012) Prospective study on metabolic factors and risk of prostate cancer. Cancer 118:24, pages 6199-6206.
Crossref
Crossref
Xiaoye Zhu, Pim J van Leeuwen, Erik Holmberg, Meelan Bul, Sigrid Carlsson, Fritz H Schröder, Monique J Roobol & Jonas Hugosson. (2012) Efficacy versus effectiveness study design within the European screening trial for prostate cancer: consequences for cancer incidence, overall mortality and cancer-specific mortality. Journal of Medical Screening 19:3, pages 133-140.
Crossref
Crossref
Håkan Jonsson, Benny Holmström, Stephen W. Duffy & Pär Stattin. (2011) Uptake of prostate‐specific antigen testing for early prostate cancer detection in Sweden. International Journal of Cancer 129:8, pages 1881-1888.
Crossref
Crossref